Warp Sciences Emerges From Stealth With $215 Million In Funding To Build AI-Powered Drug Discovery Chemistry Labs
By Amit Chowdhry ● Yesterday at 4:25 PM
Warp Sciences, a San Francisco-based biotechnology infrastructure company, has emerged from stealth with $215 million in funding to develop a U.S.-based chemistry contract research organization (CRO) that integrates artificial intelligence, robotics, and medicinal chemistry expertise. The financing was led by Lightspeed, with participation from Premji Invest, Mayfield, IVP, Lux, Conviction, Menlo Ventures, and several other venture capital firms. Additional investors include 01 Advisors, Standard, Lowercarbon Capital, Gigascale Capital, Angular Ventures, Scribble Ventures, Uncork Capital, Innovation Endeavors, Matter VP, Zero Shot Fund, SignalFire, and Moxxie Ventures.